Episode
Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma
- Podcast
- Neuro-Oncology: The Podcast
- Published
- May 11, 2026
- Duration seconds
- 236
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-phase-1-2-bt008na-trial-focused-ultrasound-temozolomide-for-high-grade-glioma/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-phase-1-2-bt008na-trial-focused-ultrasound-temozolomide-for-high-grade-glioma.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Host/Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio Description: Shahad Abdulsahib discusses the phase 1/2 BT008NA clinical trial evaluating microbubble-enhanced transcranial focused ultrasound combined with temozolomide in patients with newly diagnosed high-grade glioma, with findings published in The Lancet Oncology in December 2025